Invention Grant
- Patent Title: Selective NR2B antagonists
- Patent Title (中): 选择性NR2B拮抗剂
-
Application No.: US14589205Application Date: 2015-01-05
-
Publication No.: US09221796B2Publication Date: 2015-12-29
- Inventor: Dalton King , Lorin A. Thompson, III , Jianliang Shi , Srinivasan Thangathirupathy , Jayakumar Sankara Warrier , Imadul Islam , John E. Macor
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D401/04
Abstract:
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
Public/Granted literature
- US20150191452A1 Selective NR2B Antagonists Public/Granted day:2015-07-09
Information query
